MacroGenics reported $-0.57 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
-0.44 -0.57 Nov/11 2025
-0.57 -0.61 Aug/14 2025


Eps Change Date
AbbVie USD 2.97 0.51 Jun/2025
Amgen USD 6.02 1.12 Jun/2025
AstraZeneca USD 2.17 0.32 Jun/2025
Biogen USD 5.47 2.45 Jun/2025
Bristol-Myers Squibb USD 1.46 0.34 Jun/2025
Daiichi Sankyo JPY 46.03 0.28 Jun/2025
Eli Lilly USD 6.31 2.97 Jun/2025
Genmab DKK 34.31 14.07 Jun/2025
Geron USD -0.02 0.01 Jun/2025
Gilead Sciences USD 2.01 0.2 Jun/2025
J&J USD 2.77 0 Jun/2025
MacroGenics USD -0.57 0.32 Jun/2025
Merck USD 2.13 0.09 Jun/2025
Pfizer USD 0.78 0.14 Jun/2025
Regeneron Pharmaceuticals USD 12.89 4.67 Jun/2025
Roche Holding CHF 8.57 1.66 Dec/2024
Xencor USD -0.41 0.25 Jun/2025